Tenaya Therapeutics Inc
TNYA
Get informed when a big investor buys or sells
+ FollowMarket Cap$87.23M
Close$
$0.59
43.5% upside
Current Fair Value
43.5% upsideUndervalued by 43.5% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $87.23 Million |
|---|---|
| Enterprise Value | $18.82 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-0.59 |
| Beta | 2.88 |
| Outstanding Shares | 217,574,637 |
Return
| Return on Equity | -148.56% |
|---|---|
| Return on Assets | -110.24% |
| Return on Invested Capital | -142.20% |
Valuation & Multiples
| P/E Ratio | -0.73 |
|---|---|
| PEG | -0.85 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | 14.09 |
| Enterprise Value to EBIT | -0.18 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | 0.51 |
| Debt to Equity | 0.14 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 12, 2026
EPS Estimate
$-0.07
Average shareholder expectationRevenue Estimate
$10.00 M
Average shareholder expectationNext Earnings Call
Expected Date
November 9, 2026
EPS Estimate
$-0.11
Average shareholder expectationRevenue Estimate
$802,500
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.0000▼ 20.59% |
|---|---|
| Total Calls | -▼ 100.00% |
| Total Puts | -▼ 100.00% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 0.02%▼ 24.84% |
|---|---|
| Total Invested | $27,793▼ 99.93% |
| Investors Holding | 2▼ 106.00% |
ESG Score
No data
About Tenaya Therapeutics Inc
2,021 employees